News

Nykredit Realkredit A/S Unveils Updated Euro Note Terms

Nykredit Realkredit A/S Unveils Updated Euro Note Terms

New Developments in Nykredit Realkredit's Euro Note Programme

Nykredit Realkredit A/S recently announced exciting updates regarding its Euro Medium Term Note Programme. The company has published the final terms for a significant issue of NOK 500,000,000 Floating Rate Senior Non-Preferred Notes, which will have a maturity date in September 2028. This issuance is part of their extensive €15,000,000,000 Euro Medium Term Note Programme originally established on 8 May 2025.

Details of the Recent Note Issue

The fresh issuance signifies Nykredit’s continuous commitment to maintaining flexibility in its debt financing activities. The final terms, dated 16 December 2025, provide essential insights for investors interested in the company’s offerings. All pertinent information can also be sourced directly from Nykredit’s official site.

About Nykredit's Euro Medium Term Note Programme

This programme allows Nykredit to issue notes with varying maturities, enabling it to raise funds effectively to support its lending activities and overall business operations. The framework is particularly tailored to meet diverse investor preferences and enhance liquidity.

Listening to Investor Needs

Nykredit Realkredit A/S recognizes the sophistication of its investor base and strives to deliver products that cater to their expectations. The issuance of Floating Rate Senior Non-Preferred Notes offers a competitive option in an evolving market landscape.

Investor Relations Contact Information

For any questions or further discussions regarding the newly released note terms, stakeholders can reach out to Nykredit Realkredit A/S’s Group Treasury. Morten Lisberg, the Head of Group Treasury, is available to provide insights at +45 44 55 10 77. Additionally, Morten Bækmand Nielsen, Head of Investor Relations, can be contacted at +45 44 55 15 21.

Frequently Asked Questions

What is the significance of the new note issuance?

The new issuance allows Nykredit to diversify its funding sources and adapt to market conditions effectively.

How can investors access the details of the final terms?

The final terms can be downloaded from Nykredit's official website.

What types of notes are included in the Euro Medium Term Note Programme?

The programme includes various types of notes, such as Fixed Rate and Floating Rate, catering to different investor preferences.

Who can investors contact for more information?

Investors can reach out to Morten Lisberg or Morten Bækmand Nielsen through the provided phone numbers for queries related to the issuance.

When are the new notes due?

The newly issued notes are due in September 2028.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing

Updated Category News Views 308

Ameripath USA's New Partnership for Recovery Housing Ameripath USA has formed a strategic partnership with Recovery Resolutions LLC to significantly improve access to high-quality Addiction Recovery Homes throughout the country. This collaboration merges Ameripath's extensive real estate expertise with Recovery Resolutions' impressive success model, boasting a 95% success...

Continue Reading
Finzly’s ISO 20022 Migration Readiness Sets Industry Standards

Updated Category News Views 311

Finzly’s Innovations in ISO 20022 Payment Standards Finzly is at the forefront of transforming how financial institutions manage payments through its state-of-the-art platform designed for modern banking needs. As the shift to SWIFT MX ISO 20022 continues, Finzly's clientele is emerging as early adopters, demonstrating a commitment to embracing new technologies that...

Continue Reading
Innovative Drug Delivery Solutions for Parkinson's Disease

Updated Category News Views 251

Serina Therapeutics' Approach to Parkinson's Disease Serina Therapeutics is at the forefront of developing new treatments for complex neurological disorders, particularly Parkinson’s disease. This progressive neurological disorder significantly impacts motor functions and quality of life for those affected. With innovative solutions on the horizon, Serina is prepared to...

Continue Reading
Waters Corporation Leader to Speak at HealthCONx Conference

Updated Category News Views 124

Waters Corporation to Participate in HealthCONx Conference Waters Corporation (NYSE: WAT), located in Milford, Massachusetts, is pleased to announce its participation in the upcoming HealthCONx Conference. Udit Batra, the President and Chief Executive Officer of Waters, will engage in an insightful fireside chat set for Wednesday, December 4th, 2024, at 10:00 AM Eastern...

Continue Reading
mRNA Synthesis and Manufacturing Market Expected to Grow Steadily

Updated Category News Views 33

Growing Insights into the mRNA Synthesis and Manufacturing Market The mRNA synthesis and manufacturing market is on a promising trajectory, with projections indicating substantial growth from USD 624.4 million to USD 738.3 million by 2029. This expansion translates into a compound annual growth rate (CAGR) of 3.4%. Several factors are propelling this growth, including an...

Continue Reading